China

R&D

5 takeaways from JP Morgan 2025

I’m back from another week in San Francisco, where as usual I heard from experts and prognosticators about their expectations for the coming year in biotech.

R&D

Innovative sublingual medication for improved stroke care

Stroke poses a major threat to public health, and this threat is predicted to worsen in the years to come.

News

Lilly's Alzheimer's drug Kisunla is cleared in China

Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest drugs market.

News

Kelun's MSD-partnered TROP2 drug gets first okay in China

Kelun-Biotech has become the second drugmaker to bring a TROP2 ADC to regulatory approval, after its sac-TMT drug was cleared in China

Market Access

Navigating new risks: How China’s Anti-Espionage Law could i...

The pharmaceutical industry is facing another challenge as China seems to strengthen its Anti-Espionage Law, which introduces uncertainties that could disrupt the global supply of essential

News

AZ confirms China president has been detained

AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities, after confirming he was under investigation last week.

5 takeaways from JP Morgan 2025

Innovative sublingual medication for improved stroke care

Lilly's Alzheimer's drug Kisunla is cleared in China

Kelun's MSD-partnered TROP2 drug gets first okay in China

Navigating new risks: How China’s Anti-Espionage Law could i...

AZ confirms China president has been detained

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

China

Editor's Picks